Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Richez

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancerJ P Sculier, J J Lafitte, A Efremidis, et al.
New Microbes and New Infections|January 20, 2018
Taxonogenomic description of four new <i>Clostridium</i> species isolated from human gut: <i>'Clostridium amazonitimonense'</i>, <i>'Clostridium merdae'</i>, <i>'Clostridium massilidielmoense'</i> and <i>'Clostridium nigeriense'</i>M T Alou, S Ndongo, L Frégère, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancerJ-P Sculier, J-J Lafitte, T Berghmans, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1996
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC)M Borges, J P Sculier, M Paesmans, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2004
Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapyT Berghmans, J J Lafitte, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancerJ P Sculier, J J Lafitte, A Efremidis, et al.
New Microbes and New Infections|January 20, 2018
Taxonogenomic description of four new <i>Clostridium</i> species isolated from human gut: <i>'Clostridium amazonitimonense'</i>, <i>'Clostridium merdae'</i>, <i>'Clostridium massilidielmoense'</i> and <i>'Clostridium nigeriense'</i>M T Alou, S Ndongo, L Frégère, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancerJ-P Sculier, J-J Lafitte, T Berghmans, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
Pageof 3